Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GN10732 structure
    GN10732Oroxin B
    CAS: 114482-86-9
    纯度: >99.50%

    Oroxin B (OB) 是从中草药 Oroxylum indicum (L.) Vent 中分离得到的黄酮类化合物。Oroxin B (OB) 具有明显的抑制作用,通过上调 PTEN、下调 PTEN 诱导肝癌细胞早期凋亡而不是晚期凋亡COX-2、VEGF、PI3K 和 p-AKT.Oroxin B (OB) 在恶性淋巴瘤细胞中选择性诱导肿瘤抑制性 ER 应激。

  • GN10733 structure
    GN10733Carnosic acid
    CAS: 3650-09-7
    纯度: >97.00%

    An antioxidant

  • GN10734 structure
    GN10734Polyphyllin B
    CAS: 76296-72-5

    Polyphyllin B是巴黎根中最重要的皂苷之一,对多种癌细胞具有毒性作用。 Polyphyllin B 通过激活半胱天冬酶和细胞周期阻滞诱导细胞凋亡。

  • GN10740 structure
    GN10740Tetrahydropalmatine
    CAS: 10097-84-4
    纯度: >99.00%

    四氢巴马汀具有镇痛作用。

  • GN10741 structure
    GN10741Garcinone D
    CAS: 107390-08-9
    纯度: >98.00%

    A xanthone with diverse biological activities

  • GN10751 structure
    GN10751Dictamnine
    CAS: 484-29-7
    纯度: >98.50%

    An alkaloid with diverse biological activities

  • GN10776 structure
    GN10776Obacunone
    CAS: 751-03-1
    纯度: >98.00%

    Obacunone 是从 Marsh White 葡萄柚的种子中分离出来的,通过诱导细胞凋亡表现出抗肿瘤活性。

  • GN10778 structure
    GN10778Picroside II
    CAS: 39012-20-9
    纯度: >95.00%

    A flavonoid with diverse biological activities

  • GN10783 structure
    GN10783(R) Ginsenoside Rh2
    CAS: 112246-15-8
    纯度: >98.00%

    A steroid glycoside with diverse biological activities

  • GN10788 structure
    GN10788Cucurbitacin Ⅱb
    CAS: 50298-90-3
    纯度: >98.00%

    A natural triterpene

  • GN10797 structure
    GN10797Tangeretin
    CAS: 481-53-8
    纯度: >98.00%

    Tangeretin是一种从柑橘皮中提取的天然多甲氧基黄酮化合物,是Notch-1的抑制剂。

  • GN10800 structure
    GN1080020(S)-NotoginsenosideR2
    CAS: 80418-25-3
    纯度: >98.00%

    20(S)-NotoginsenosideR2 是一种从三七中新分离的三七皂苷,对 6-OHDA 诱导的氧化应激和细胞凋亡具有神经保护作用。

  • GN10801 structure
    GN10801Senkyunolide I
    CAS: 94596-28-8
    纯度: >99.50%

    Senkyunolide I 是从川芎中分离出来的,是一种抗偏头痛化合物。

  • GN10802 structure
    GN10802Brazilin
    CAS: 474-07-7
    纯度: >98.00%

    A flavonoid with diverse bioactivites

  • GN10805 structure
    GN10805Protopanaxdiol
    CAS: 30636-90-9
    纯度: >98.00%

    A sapogenin with anticancer and antibacterial activities

  • GC11218 structure
    GC11218Z-VDVAD-FMK
    CAS: 210344-92-6
    纯度: >98.00%

    Z-VDVAD-FMK是一种不可逆的、具有细胞渗透性的caspase-2特异性抑制剂。

  • GC11594 structure
    GC11594RG7388
    CAS: 1229705-06-9
    纯度: >99.50%

    RG7388是一种具有口服活性的MDM2(IC 50 =6nM)拮抗剂,RG7388通过抑制MDM2-p53相互作用来激活p53通路。

  • GC12287 structure
    GC12287Z-DEVD-FMK
    CAS: 210344-95-9
    纯度: >95.00% / >98.00% / >98.50%

    Z-DEVD-FMK是一种特异性的不可逆的半胱氨酸-天冬氨酸蛋白酶3(caspase-3)抑制剂,IC 50 为18μM。

  • GC12725 structure
    GC12725VX-765
    CAS: 273404-37-8
    纯度: >99.50% / >98.00%

    VX-765 是一种新开发的选择性小分子 caspase-1 抑制剂,可通过血脑屏障并在体外和体内减少炎症。

  • GC12791 structure
    GC127913,3'-Diindolylmethane
    CAS: 1968-05-4
    纯度: >98.00%

    A phytochemical with antiradiation and chemopreventative effects

  • GC13413 structure
    GC13413Z-VEID-FMK
    CAS: 210344-96-0

    Caspase-6抑制剂

  • GC14165 structure
    GC14165Tenovin-1
    CAS: 380315-80-0
    纯度: >99.50%

    A small molecule activator of p53

  • GC16744 structure
    GC16744Z-DQMD-FMK

    Caspase-3 inhibitor,cell-permeable

  • GC11713 structure
    GC11713Q-VD(OMe)-OPh

    Pan-caspase inhibitor